A medication originally used for patients with diabetes is the first to help people with heart failure and could revolutionize treatment. Early research had shown that SGLT2 inhibitors could help around half of heart failure patients -- those with a condition known as reduction ejection fraction. But a new study shows that the medication could be beneficial for all heart failure patients -- including those with a second type of heart failure called preserved ejection fraction.
from Top Health News -- ScienceDaily https://ift.tt/3lttSpb
Subscribe to:
Post Comments (Atom)
Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO
However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...
-
While sales to original equipment manufacturers declined 16.3% year on year in FY20, the replacement market sales declined by a modest 2.6% ...
-
India's passenger vehicle sales are expected to grow between 3-5 percent in the current fiscal year, after expanding at the slowest pace...
-
The earnings momentum has been quite resilient and the policy momentum quite focused towards improving the infrastructure and attractiveness...
No comments:
Post a Comment